Neuropharmacology, pharmacogenetics and pharmacogenomics of aggression: The zebrafish model

Pharmacol Res. 2019 Mar:141:602-608. doi: 10.1016/j.phrs.2019.01.044. Epub 2019 Jan 29.

Abstract

The zebrafish (Danio rerio) is increasingly utilized as a powerful new model organism in neurobehavioral research. Aggression is a common symptom of many CNS disorders, has some genetic determinants and can be modulated pharmacologically in humans and animal model species. Mounting evidence suggests zebrafish as a useful tool to study neurobiology of aggression, and its pharmacological and genetic regulation. Here, we discuss mechanisms of zebrafish aggression and their pharmacological, pharmacogenetic and pharmacogenomic models, as well as recent developments and existing challenges in this field. We also emphasize the growing utility of zebrafish models in translational neuropharmacological research of aggression, fostering future discoveries of potential therapeutic agents for aggressive behavior.

Keywords: Aggression; Animal models; CNS; Epigenetics; Pharmacological modulation.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Aggression* / drug effects
  • Animals
  • Central Nervous System Agents / pharmacology
  • Central Nervous System Diseases / drug therapy
  • Central Nervous System Diseases / genetics*
  • Central Nervous System Diseases / pathology
  • Disease Models, Animal*
  • Neuropharmacology
  • Pharmacogenetics
  • Translational Research, Biomedical
  • Zebrafish / genetics*
  • Zebrafish / physiology

Substances

  • Central Nervous System Agents